Methodological aspects of the prevention of contrast-induced acute kidney damage during angiographic studies and interventions using radiocontrast agents
https://doi.org/10.18705/2311-4495-2020-7-4-83-90
Abstract
Procedures using iodine-containing X-ray contrast agents pose a risk to kidney function, especially in patients with pre-existing renal dysfunction. Contrast-induced nephropathy is the third most common cause of acute kidney injury, and in high-risk groups the incidence of contrast-induced nephropathy may approach 20-30 %. Therefore, assessing and reducing the risk of contrast-induced nephropathy remains a very important issue. There is no treatment for contrast-induced nephropathy in the world, so the main focus is on its prevention. This methodological article describes in detail the definition, methodology for assessing the risks of development and diagnosis of contrast-induced acute kidney injury. The main aspects of prevention of contrast-induced acute kidney injury during angiographic studies and interventions using X-ray contrast agents are also considered. Particular attention is paid to hydration, as the main method of hydration of contrast-induced acute kidney injury, taking into account the somatic status of the patient.
About the Authors
Yu. V. Lavrishcheva
Almazov National Medical Research Centre
Russian Federation
Competing Interests: not
Russian Federation
Lavrishcheva Iuliia V. – Nephrologist.
3 Kirov Military Medical Academy, Saint Petersburg
Competing Interests: not
A. O. Konradi
Almazov National Medical Research Centre
Russian Federation
Competing Interests: not
Russian Federation
Konradi Alexandra O. - MD, PhD, Professor, the Deputy Director on Science, Head of the Research Institute.
Saint Petersburg
Competing Interests: not
A. A. Jakovenko
Academician I.P. Pavlov First Saint Petersburg State Medical University
Russian Federation
Competing Interests: not
Russian Federation
Yakovenko Aleksandr A. - MD, PhD, Associate Professor, Department of Nephrology and Dialysis.
Saint Petersburg
Competing Interests: not
M. V. Zakharov
Kirov Military Medical Academy
Russian Federation
Competing Interests: not
Russian Federation
Zakharov Michail V. - MD. PhD, Associate Professor, Department of Nephrology and Efferent Therapy.
SaintPetersburg
Competing Interests: not
References
1. Kog MM, Aslan N, Kao AP, et al. Evaluation of X-ray tomography contrast agents: a review of production, protocols, and biological applications. Microsc Res Tech. 2019; 82(6): 812-848.
2. Zuo T, Jiang L, Mao S, et al. Hyperuricemia and contrast-induced acute kidney injury: a systematic review and meta-analysis. Int J Cardiol. 2016; 224: 286-294.
3. Ozrazgat-Baslanti T, Thottakkara P, Huber M, et al. Acute and chronic kidney disease and cardiovascular mortality after major surgery. Ann Surg. 2016; 264 (6): 987-996.
4. Chalikias G, Drosos I, Tziakas DN. Contrast-induced acute kidney injury: an update. Cardiovasc Drugs Ther. 2016; 30 (2): 215-228.
5. KDIGO clinical practice guideline for acute kidney injury. Kidney International Supplements. 2012; 2 (1): 1-126.
6. van der Molen AJ, Reimer P, Dekkers IA, et al. Post-contrast acute kidney injury - Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors: Recommendations for updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol. 2018; 28 (7): 2845-2855.
7. Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA. 2004; 291 (19): 2328-2334.
8. Brar SS, Hiremath S, Dangas G, et al. Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2009; 4 (10): 1584-1592.
9. Sun Z, Fu Q, Cao L, et al. Intravenous N-acetylcysteine for prevention of contrast-induced nephropathy: a meta-analysis of randomized, controlled trials. PLoS One. 2013; 8 (1): e55124.
10. Zagler A, Azadpour M, Mercado C, et al. N-acetylcysteine and contrast-induced nephropathy: a metaanalysis of 13 randomized trials. Am Heart J. 2006; 151(1): 140-145.
11. Prince MR, Zhang H, Morris M, et al. Incidence of nephrogenic systemic fibrosis at two large medical centers. Radiology. 2008; 248 (3): 807-816.
12. Subramaniam RM, Suarez-Cuervo C, Wilson RF, et al. Effectiveness of prevention strategies for contrast-induced nephropathy: a systematic review and metaanalysis. Ann Intern Med. 2016; 164 (6): 406-416.
13. Barbieri L, Verdoia M, Suryapranata H, et al. Impact of vascular access on the development of contrast induced nephropathy in patients undergoing coronary angiography and/or percutaneous coronary intervention. Int J Cardiol. 2019; 275: 48-52.
14. van der Molen AJ, Reimer P, Dekkers IA, et al. Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients: Recommendations for updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol. 2018; 28(7): 2856-2869.
15. Krestan C. Contrast media — Guidelines for practical use. Radiologe. 2019; 59(5): 444-453.
Review
For citations:
Lavrishcheva Yu.V., Konradi A.O., Jakovenko A.A., Zakharov M.V. Methodological aspects of the prevention of contrast-induced acute kidney damage during angiographic studies and interventions using radiocontrast agents. Translational Medicine. 2020;7(4):83-90. (In Russ.) https://doi.org/10.18705/2311-4495-2020-7-4-83-90
Views:
1286
Email this article 